What is the current stock price of Arch Therapeutics, Inc. (ARTH)?

As of the latest market data, Arch Therapeutics, Inc. (ARTH) is trading at $0.00. The stock has seen a gain of 0.00% today.

Does Arch Therapeutics, Inc. (ARTH) pay a dividend?

Based on current data, Arch Therapeutics, Inc. does not have a confirmed active dividend policy.

What is the market cap of Arch Therapeutics, Inc.?

The current market capitalization of Arch Therapeutics, Inc. (ARTH) is approximately unavailable.

ARTH

Arch Therapeutics, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $1.57

ARTH NEWS

defenseworld.net

Feb 1

SANUWAVE Health (OTCMKTS:SNWV) and Arch Therapeutics (OTCMKTS:ARTH) Critical Review

Profitability This table compares Arch Therapeutics and SANUWAVE Health's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Arch Therapeutics -8,257.70% N/A -730.22% SANUWAVE Health -1.33% -23.83% -20.60% Institutional and Insider Ownership 6.9% of Arch Therapeutics shares are held by institutional investors. Comparatively, 42.5% of SANUWAVE Health

Company Profile

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2013-01-02

Beta

4.03

Websitewww.archtherapeutics.com↗